Cutler Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-300
Closed -$1K 4331
2018
Q3
$1K Buy
+300
New +$1.36K ﹤0.01% 3800
2018
Q1
Sell
-5,700
Closed -$66.4K 4915
2017
Q4
$71K Sell
5,700
-11,708
-67% -$143K ﹤0.01% 1611
2017
Q3
$206K Buy
17,408
+16,908
+3,382% +$251K 0.01% 1159
2017
Q2
$7K Buy
+500
New +$6.67K ﹤0.01% 4535
2016
Q4
Sell
-1,000
Closed -$8.98K 6990
2016
Q3
$8K Sell
1,000
-1,875
-65% -$14.8K ﹤0.01% 4460
2016
Q2
$22K Buy
2,875
+2,100
+271% +$16.3K ﹤0.01% 3258
2016
Q1
$6K Sell
775
-2,201
-74% -$18.3K ﹤0.01% 4654
2015
Q4
$27K Buy
+2,976
New +$25.8K ﹤0.01% 3104

Other funds holding MDXG

Cutler Group's MDXG Position: Q4 2018 in Review

Cutler Group sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 300 shares — an estimated $1K sold.

Cutler Group first reported a position in MDXG in Q4 2015 and held it in 8 quarters. The position peaked at $206K in Q3 2017. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

  • Cutler Group reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
  • Cutler Group sold 300 MiMedx Group shares in Q4 2018, an estimated $1K.
  • Cutler Group first reported a position in MiMedx Group in Q4 2015 and held it in 8 quarters.
  • Cutler Group's MiMedx Group position peaked at $206K in Q3 2017.
  • 38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on Cutler Group's 13F filing for Q4 2018, filed 5 Feb 2019.